By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 October 2023 Using precision medicine in diabetes means that treatment of the disease and its complications can become more precise and accurate. Photo: iStock/Maya23K An international consensus report on diabetes identifies the potential for diabetes screening, better classification of type 2 diabetes, and biomarkers th

https://www.ludc.lu.se/article/new-report-highlights-opportunities-and-challenges-precision-diabetes-medicine - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 6 November 2023 Rashmi Prasad is awarded the Medeon stipend 2023 for her her research on heritability of type 2 diabetes. The stipend will be presented during the World Diabetes Day Skåne event. Photo: Petra Olsson How do heritability and the fetal environment affect the risk for the child to develop type 2 diabetes? This

https://www.ludc.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 15 November 2023 Magnus Cinthio, Isabel Goncalves and Tobias Erlöv win Lund University’s and Sparbanken Skåne’s award for Future Innovations to develop their idea further. Photo: Kennet Ruona Diabetes researcher and cardiologist Isabel Goncalves at Lund University Diabetes Centre (LUDC) has teamed up with ultrasound resear

https://www.ludc.lu.se/article/innovation-aims-identify-dangerous-atherosclerotic-plaques-wins-prize - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 December 2023 Tina Rönn, Charlotte Ling, and Karl Bacos have led the work on a study that examines whether epigenetic changes contribute to the development of type 2 diabetes. Photo: Petra Olsson Do epigenetic changes cause type 2 diabetes, or do the changes occur only after a person has become ill? A new study by resea

https://www.ludc.lu.se/article/epigenetic-changes-can-cause-type-2-diabetes - 2025-05-13

By press [at] med [dot] lu [dot] se (Faculty of Medicine at Lund University) - published 26 January 2024 Out of the 195 biomarkers examined, 13 were significantly associated with cardiovascular risk in people with type 2 diabetes. Photograph: iStock An international team of researchers has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease

https://www.ludc.lu.se/article/new-study-biomarkers-improve-prediction-cardiovascular-disease-type-2-diabetes - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 15 February 2024 Anna Blom and Ben C King have discovered that C3 protein protects insulin-producing cells. Photo: Rebecca Rosberg Much research on diabetes focuses on understanding what happens when the insulin-producing cells are destroyed. Researchers at Lund University have instead chosen to investigate what protects t

https://www.ludc.lu.se/article/protein-protects-insulin-producing-cells - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 28 February 2024 Coordinator Allan Vaag and Vice Coordinator Lena Eliasson lead the activities at EXODIAB and LUDC in close collaboration. Photograph: Petra Olsson Diabetes researchers Allan Vaag and Lena Eliasson are the new coordinators of Lund University Diabetes Centre (LUDC) and the strategic research area EXODIAB (Ex

https://www.ludc.lu.se/article/new-coordinators-strategic-research-area-diabetes - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 20 February 2024 Tune H Pers is the recipient of the Leif C. Groop Award for Outstanding Diabetes Research in 2024. Photograph: Peter Andrew Stanners Do you think that people with obesity have themselves to blame? Tune H Pers tries to dispel persistent myths through his research on the brain's role in the development of ob

https://www.ludc.lu.se/article/tune-h-pers-receives-award-outstanding-research-obesity-and-diabetes - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 18 April 2024 Vikas Yadav, Jan Nilsson, and Filiz Serifler at Lund University Diabetes Centre have contributed to the studies of the antibody that neutralises oxidised LDL particles. Photograph: Petra Olsson A treatment that has reduced plaque development in mice has now been tested in people with psoriasis. Jan Nilsson at

https://www.ludc.lu.se/article/new-treatment-atherosclerosis-may-reduce-risk-dying-heart-attack - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 21 May 2024 Sebastian Kalamajski edits fat cells with the editing technique CRISPR-Cas9. The aim with his project is to identify genetic variants and molecular pathways behind obesity that does not lead to type 2 diabetes. Photograph: Petra Olsson Why are some people with obesity protected from type 2 diabetes? Who is at r

https://www.ludc.lu.se/article/research-obesity-and-gestational-diabetes-receive-support-hjelt-diabetes-foundation - 2025-05-13

Published 22 September 2016 People with a hereditary risk of obesity lose as much weight as a result of better diet, exercise and weight loss drugs as the rest of the population, according to an international study presented in The BMJ. “This indicates that even in people at genetic risk of obesity, lifestyle change is an effective way to lose weight”, says Professor Paul Franks of Lund University

https://www.ludc.lu.se/article/no-link-between-obesity-gene-and-intentional-weight-loss - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 19 June 2024 A new method can be used for large-scale screening for type 1 diabetes. The blood test can be done at home. Photograph: Petra Olsson Interest in type 1 diabetes screening is growing as methods improve and new treatments become available to more patients. New research at Lund University demonstrates how screeni

https://www.ludc.lu.se/article/new-method-allows-large-scale-screening-autoimmune-diseases - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 June 2024 The EAT-Lancet diet emphasises a plant-based diet where whole grains, fruits, vegetables, nuts and legumes comprise a greater proportion of foods consumed. Meat and dairy products are consumed in smaller proportions. Photograph: iStock/Magda Tymczyj The EAT-Lancet diet is a framework designed to promote enviro

https://www.ludc.lu.se/article/research-paves-way-sustainable-dietary-recommendations - 2025-05-13

Published 4 July 2016 The dream of finding the “diabetes gene” is dead. However, partly thanks to Leif Groop – professor and multiple award recipient for his ground-breaking research – we will look at type 2 diabetes in a whole new way in the future. He is now retiring, and in an interview with diabetesportalen.se he looks back on his eventful career in research. The study that since 2006 has been

https://www.ludc.lu.se/article/time-burie-lada-interview-leif-groop - 2025-05-13

Published 30 June 2016 Researchers at Lund University in Sweden have discovered that the appetite hormone CART is regulated by glucose and is found in greater quantity in people with type 2 diabetes. “This could be the body’s own defence mechanism to lower blood sugar levels in case of type 2 diabetes”, says Associate Professor Nils Wierup, in charge of the study. The study shows that the appetite

https://www.ludc.lu.se/article/antidiabetic-effects-discovered-appetite-hormone-cart - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 3 July 2024 Jan Nilsson's research group has identified a substance that stimulates the repair capacity and growth of vascular cells. Biomedical analyst Filiz Serifler has contributed to the project. Photo: Petra Olsson Heart attack and stroke are common complications of diabetes, as the body's ability to repair and form v

https://www.ludc.lu.se/article/new-peptide-may-reduce-risk-diabetes-complications - 2025-05-13

By press [at] med [dot] lu [dot] se (The Faculty of Medicine at Lund University) - published 19 July 2024 An international consortium presents new guidelines that may increase the clinical relevance of precision medicine research. Photo: istock.com/xubingruo Precision medicine seeks to reduce errors and improve accuracy in medical and health recommendations, but better evidence is needed to fulfil

https://www.ludc.lu.se/article/new-guidelines-aim-increase-accuracy-precision-medicine-research - 2025-05-13

By noomi [dot] egan [at] fsi [dot] lu [dot] se (Noomi Egan) - published 19 September 2024 Åke Lernmark's studies of diabetes-related autoantibodies have contributed to increasing knowledge about type 1 diabetes so that it may become possible to start screening children for the disease. Photograph: Kennet Ruona During his more than 50-year career, diabetes researcher Åke Lernmark has made several s

https://www.ludc.lu.se/article/scientist-who-paving-way-screening-type-1-diabetes - 2025-05-13

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 10 December 2024 Isabel Gonçalves and Andreas Edsfeldt have analysed atherosclerotic plaques from patients who have type 2 diabetes and patients who do not have the disease. Photo: Petra Olsson People with type 2 diabetes have a higher risk of developing cardiovascular disease and dying prematurely due to atherosclerosis.

https://www.ludc.lu.se/article/new-explanation-dangerous-atherosclerotic-plaques-type-2-diabetes - 2025-05-13

By anna [dot] hellgren [at] med [dot] lu [dot] se (Anna Hellgren) - published 24 October 2024 Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. Photo: iStock/Suriyawut Suriya Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. In work led by researchers

https://www.ludc.lu.se/article/new-precision-medicine-approach-helps-detect-subgroups-people-obesity-high-risk-diabetes-and-heart - 2025-05-13